Jazz Pharma to pay $1B for rare disease drug co.

Jazz Pharmaceuticals PLC plans to buy drug maker Gentium SpA for roughly $1 billion in a cash deal aimed at expanding its rare disease drug portfolio.

http://www.hispanicbusiness.com/2013/12/19/jazz_pharma_to_pay_1b_for.htm